AGPAT2-CDC42SE1 Fusion FISH Probe
The AGPAT2-CDC42SE1 Fusion FISH Probe is used to confirm a fusion of the AGPAT2 and CDC42SE1 genes. The fusion of the AGPAT2 and CDC42SE1 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| AGPAT2-CDC42SE1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| AGPAT2-CDC42SE1-20-AQAQ | 20 (40 μL) | 200 μL |
|
AGPAT2 Gene Summary
This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Gene Name: 1-acylglycerol-3-phosphate O-acyltransferase 2
Chromosome: CHR9: 139567594 -139581911
Locus: 9q34.3
CDC42SE1 Gene Summary
The CDC42 Small Effector 1 (CDC42SE1) gene is located on chr1 :151023446-151032125 at 1q21.3.
Gene Name: CDC42 Small Effector 1
Chromosome: CHR1: 151023446 -151032125
Locus: 1q21.3
Gene Diseases
The AGPAT2 CDC42SE1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|